Anti-Human KIR2DL1/CD158a&KIR2DL2/CD158b1&KIR2DL3/CD158b2&KIR2DS1/CD158h&KIR2DS2 Reference Antibody (Lirilumab, RUO) (HW759016)

Name: Anti-Human KIR2DL1/CD158a&KIR2DL2/CD158b1&KIR2DL3/CD158b2&KIR2DS1/CD158h&KIR2DS2 Reference Antibody (Lirilumab, RUO)
Brand: abinScience
SKU: HW759016
Price: 176 USD
Availability: InStock

Datasheet Share product Copy info

Price(USD):

Spec:

100ug
1mg
5mg
10mg
25mg
50mg
100mg

Number:

Get quote

Overview
Images
References
Datasheet
SDS

Overview

Catalog No.	HW759016
Description	Lirilumab (HW759016) is a research-grade recombinant antibody targeting CD158. Produced in mammalian cells with native-like glycosylation. Highlights ●Research Grade — For PK/PD studies, assay development, and ADA research. ●Native Glycosylation — Mammalian expression ensures native-like patterns.
Species reactivity	Human
Applications	ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Host species	Human
Isotype	IgG4-kappa
Expression system	Mammalian cells
Clonality	Monoclonal
Target	CD158 antigen-like family member A, KIR2DL1, Killer cell immunoglobulin-like receptor 2DL1, Natural killer-associated transcript 1, NKAT-1, MHC class I NK cell receptor, CD158A, p58 natural killer cell receptor clones CL-42/47.11, CD158a, p58.1 MHC class-I-specific NK receptor, NKAT1, p58 NK receptor CL-42/47.11, p58 NK receptor CL-43, NKAT-6, NKAT6, MHC class I NK cell receptor, CD158 antigen-like family member B1, CD158b1, p58 natural killer cell receptor clone CL-43, Natural killer-associated transcript 6, CD158B1, KIR2DL2, Killer cell immunoglobulin-like receptor 2DL2, NKAT2b, KIR2DL3, p58 natural killer cell receptor clone CL-6, p58.2 MHC class-I-specific NK receptor, CD158 antigen-like family member B2, MHC class I NK cell receptor, KIR-023GB, Killer inhibitory receptor cl 2-3, p58 NK receptor CL-6, CD158b2, Killer cell immunoglobulin-like receptor 2DL3, Natural killer-associated transcript 2, CD158B2, KIRCL23, NKAT-2, NKAT2a, NKAT2
Endotoxin level	< 10 EU/mg
Purity	>95% purity by SDS-PAGE.
Purification	Protein A/G purified from cell culture supernatant.
Accession	P43626 & P43627 & P43628
Form	Liquid
Storage buffer	0.01M PBS pH 7.4 Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.
Stability and Storage	Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternate Names	BMS-986015, IPH2102, 1000676-41-4
Background	Lirilumab (IPH2102) is an anti-KIR monoclonal antibody, and shows antitumor activity. Lirilumab can be used in Leukemia, squamous cell carcinoma of the head and neck (SCCHN) research.
Note	For research use only. Not suitable for clinical or therapeutic use.

Images

SEC-HPLC

SEC-HPLC detection for Research Grade Lirilumab.
Bioactivity

Detects Human CD158b1/KIR2DL2 in indirect ELISAs.
SDS-PAGE

SDS-PAGE for Research Grade Lirilumab.

References

Datasheet

Anti-Human KIR2DL1/CD158a&KIR2DL2/CD158b1&KIR2DL3/CD158b2&KIR2DS1/CD158h&KIR2DS2 Reference Antibody (Lirilumab, RUO).pdf

Download SDS PDF

Formula

Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)

Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.

Mass

Concentration

Volume

Molecular Weight *

g/mol

Formula

C₁ × V₁ = C₂ × V₂

Enter any 3 of the 4 values to solve for the unknown.

Stock Solution

C₁ (Stock Conc.)

V₁ (Stock Vol.)

Working Solution

C₂ (Working Conc.)

V₂ (Working Vol.)

Recombinant Proteins

Antibodies

Assay Kits

Anti-Human KIR2DL1/CD158a&KIR2DL2/CD158b1&KIR2DL3/CD158b2&KIR2DS1/CD158h&KIR2DS2 Reference Antibody (Lirilumab, RUO) (HW759016)

Overview

Images

References

Datasheet

SDS

Quick access

Contact Us